GPP
FRTX

Great Point Partners’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Great Point Partners’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-269
Closed -$800K – 42
2015
Q1 		$800K Sell
269
-403
-60% -$1.29M 0.35% 28
2014
Q4 		$2.22M Sell
672
-288
-30% -$1.02M 1.07% 20
2014
Q3 		$3.39M Buy
960
+296
+45% +$1.15M 1.46% 24
2014
Q2 		$2.55M Buy
+664
New +$2.5M 1.13% 27

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Great Point Partners's FRTX Position: Q2 2015 in Review

Great Point Partners sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2015, closing a stake of 269 shares — an estimated $800K sold.

Great Point Partners first reported a position in FRTX in Q2 2014 and held it in 4 quarters. The position peaked at $3.39M in Q3 2014. 58 funds tracked by Wall St. Rank hold FRTX as of Q2 2015.

  • Great Point Partners reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Great Point Partners sold 269 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2015, an estimated $800K.
  • Great Point Partners first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2014 and held it in 4 quarters.
  • Great Point Partners's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $3.39M in Q3 2014.
  • 58 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2015.

Based on Great Point Partners's 13F filing for Q2 2015, filed 14 Aug 2015.